BOLD stock

Boundless Bio, Inc. Common Stock (BOLD) financials · $24.6M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Boundless Bio, Inc. Common Stock (BOLD) $24.6M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$63.6M-$73.3M
Net Income-$58.2M-$65.4M
EPS (Diluted)-$2.60-$3.85
Cached annual balance sheet
LineFY2025FY2024
Total Assets$157.1M$206.4M
Current Assets$109.6M$154.4M
Cash & Equivalents$17.9M$26.6M
PP&E$3.22M$4.32M
Total Liabilities$58.4M$55.8M
Current Liabilities$12.5M$8.13M
Shareholders' Equity$98.7M$150.6M
Retained Earnings-$259.7M-$201.5M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$46.7M-$60.8M
CapEx$546.0K$2.54M
Investing Cash Flow$37.8M-$26.1M
Financing Cash Flow$141.0K$89.8M
Net Change in Cash-$8.72M$2.88M
Free Cash Flow-$47.2M-$63.4M
These statements as JSON? API free 100/day

FAQ

What is BOLD P/E and revenue?

Boundless Bio, Inc. Common Stock (BOLD) $24.6M cap.

What is BOLD revenue?

BOLD income-statement cache has no revenue figure yet.

Is BOLD profitable?

Boundless Bio, Inc. Common Stock last cached net income is -$58.2M (FY2025).

What are BOLD total assets?

Boundless Bio, Inc. Common Stock last cached total assets are $157.1M (FY2025).

What is BOLD free cash flow?

Boundless Bio, Inc. Common Stock last cached free cash flow is -$47.2M (FY2025).

Not investment advice. Cached statements, not a live tape.